Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Total debt

Total debt at other companies

TFX
TeleflexTFX
$2.78B+38.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.06B+15.6%
IAR
Integra LifeSciencesIART
$1.98B+3.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$821.56M+0.5%
PDE
Pro-Dex, Inc.PDEX
$15.98M+43.2%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
——

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

$210.0Klong term debt=$210K

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's total debt?
Utah Medical Products (UTMD) reported total debt of $210K in Q1 2026.
What is the long-term trend for Utah Medical Products's total debt?
Over 5 years (2020 to 2025), Utah Medical Products's total debt has grown at a -5.3% compound annual growth rate (CAGR), from $376K to $286K.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.